| Literature DB >> 29052792 |
Soumendranath Bhakat1, Emil Åberg1, Pär Söderhjelm2.
Abstract
Advanced molecular docking methods often aim at capturing the flexibility of the protein upon binding to the ligand. In this study, we investigate whether instead a simple rigid docking method can be applied, if combined with multiple target structures to model the backbone flexibility and molecular dynamics simulations to model the sidechain and ligand flexibility. The methods are tested for the binding of 35 ligands to FXR as part of the first stage of the Drug Design Data Resource (D3R) Grand Challenge 2 blind challenge. The results show that the multiple-target docking protocol performs surprisingly well, with correct poses found for 21 of the ligands. MD simulations started on the docked structures are remarkably stable, but show almost no tendency of refining the structure closer to the experimentally found binding pose. Reconnaissance metadynamics enhances the exploration of new binding poses, but additional collective variables involving the protein are needed to exploit the full potential of the method.Entities:
Keywords: D3R; Docking; MD simulation; Pose prediction; Protein–ligand binding; Reconnaissance metadynamics
Mesh:
Substances:
Year: 2017 PMID: 29052792 PMCID: PMC5767213 DOI: 10.1007/s10822-017-0074-x
Source DB: PubMed Journal: J Comput Aided Mol Des ISSN: 0920-654X Impact factor: 3.686
Results of the docking
Evaluation of the RMSD towards experiment for the top-predicted pose (first), best of the five submitted poses (best), best of all poses found in the analysis stage of the docking including the new crystal structures (globally best), and top-predicted pose when both old and new crystal structures were used (globally first). The docking score of each pose is also given. For improved readability, the entries for “best” are shown in bold face if they are not identical to “first”. The shaded table entries represent poses with an RMSD below 2 Å. The ligands are classified into types listed in Table 3
Average RMSD in Å for the various types of ligands using the best docking result from the blind stage (old) and the analysis stage (global), respectively
| Group | Old | Global |
|---|---|---|
| Benzimidazoles (benz) | 1.36 | 0.71 |
| Sulfonamides (sulf) | 2.32 | 0.87 |
| Isoxazoles (isox) | 3.61 | 1.09 |
| Spirocycles (spir) | 4.02 | 1.90 |
| Miscellaneous (misc) | 5.50 | 2.33 |
Summary of the docking results
| Cutoff (Å) | Number of correct poses | |||||
|---|---|---|---|---|---|---|
| First | Best | Globally first | Globally best |
|
| |
| 1.0 | 7 | 11 | 11 | 22 | 17 | 18 |
| 1.5 | 11 | 19 | 17 | 27 | 23 | 21 |
| 2.0 | 13 | 21 | 19 | 29 | 26 | 26 |
| 2.5 | 13 | 22 | 20 | 30 | 28 | 26 |
| 3.0 | 13 | 24 | 20 | 33 | 29 | 26 |
Each line reports the number of ligands for which the various docking strategies in Table 1 found the “correct” pose, if evaluated by a given RMSD cutoff threshold. Just as in Table 1, the “first” pose is the submitted top-scored pose, the “best” pose is the pose that retrospectively was the best of the five submitted poses, the “globally best” is the retrospectively best pose among the dockings to all (including secret) crystal structures, and the “globally first” pose is the top-scored pose among the dockings to the whole set of protein structures. For comparison, the corresponding best-pose results are shown for the two best submissions in the challenge: ixnzu and 7itmc. The 2 Å threshold is the default used throughout this study
Fig. 1Performance of the submissions to D3RGC2. The upper panel shows the distribution of the number of correctly predicted ligand poses (out of 35) over all the submissions, if the best of up to five poses was considered. The lower panel shows the corresponding results when only the first (top-predicted) pose was considered. The filled rectangles show the performance of our docking submission. Any pose with RMSD less than 2 Å towards the crystal structure was classified as correct
Summary of the MD and RMD simulations. For each ligand, up to three initial poses are considered. For each pose, the table gives the PDB ID of the crystal structure used as starting structure for the protein, the RMSD between the initial pose and experiment (init/exp; same as in Table 1), the RMSD between the MD main cluster and experiment (MD/exp), the RMSD between the MD cluster and the initial pose (MD/init), the minimum RMSD between a RMD cluster and experiment (RMD/exp), the maximum RMSD between a RMD cluster and the initial pose (RMD/init), and the number of clusters obtained in the RMD simulation. All RMSDs towards the experimental structure were calculated by the official script taking into account symmetry-equivalent atoms, whereas the rest of the RMSDs were calculated atom by atom (thus the MD/exp and MD/init values may differ even for the simulations started from experiment). In all cases, the RMSD was calculated for all non-hydrogen atoms of the ligand after aligning the atoms of the protein. All RMSD values are given in Å
| Lig | Pose | PDB | init/exp | MD/exp | MD/init | RMD/exp | RMD/init | # Clusters |
|---|---|---|---|---|---|---|---|---|
| 1 | First | 3OMK | 5.32 | 5.15 | 0.76 | 3.62 | 5.20 | 26 |
| Best | 3OLF | 2.97 | 3.84 | 3.06 | 2.93 | 5.37 | 20 | |
| Exp | 0.82 | 0.76 | 1.43 | 2.90 | 7 | |||
| 2 | First | 3OMM | 6.86 | 7.79 | 0.57 | 6.37 | 6.30 | 19 |
| Exp | 0.43 | 0.45 | 0.98 | 7.30 | 25 | |||
| 3 | First | 3P88 | 4.70 | 4.57 | 2.38 | 4.40 | 7.50 | 7 |
| Exp | 1.54 | 1.85 | 0.91 | 2.60 | 4 | |||
| 4 | First | 3P88 | 3.82 | 3.77 | 1.42 | 3.79 | 6.60 | 30 |
| Exp | 1.26 | 1.32 | 1.40 | 6.00 | 15 | |||
| 5 | First | 3OMM | 6.48 | 7.15 | 3.09 | 4.34 | 7.40 | 13 |
| Exp | 0.33 | 0.33 | 0.53 | 5.30 | 5 | |||
| 6 | First | 3OMK | 0.42 | 0.57 | 0.54 | 1.05 | 6.50 | 15 |
| Exp | 0.65 | 0.60 | 1.05 | 5.40 | 9 | |||
| 7 | First | 3OMM | 1.20 | 0.72 | 0.71 | 0.85 | 5.80 | 16 |
| Exp | 0.83 | 1.34 | 1.31 | 5.30 | 9 | |||
| 8 | First | 3OMM | 5.49 | 5.19 | 1.12 | 4.97 | 5.50 | 14 |
| Best | 3OMM | 0.92 | 1.04 | 1.02 | 1.03 | 5.02 | 5 | |
| Exp | 0.92 | 1.44 | 0.98 | 8.60 | 13 | |||
| 9 | First | 3OMK | 0.54 | 0.37 | 0.49 | 0.69 | 4.70 | 12 |
| Exp | 0.46 | 0.97 | 1.03 | 8.40 | 21 | |||
| 10 | First | 1OSH | 4.96 | 3.81 | 1.18 | 3.68 | 13.30 | 32 |
| Exp | 2.02 | 1.81 | 2.68 | 5.60 | 10 | |||
| 11 | First | 1OSH | 4.32 | 3.73 | 1.62 | 3.54 | 10.70 | 33 |
| Exp | 2.12 | 2.16 | 1.93 | 6.80 | 16 | |||
| 12 | First | 1OSH | 4.31 | 4.73 | 2.47 | 4.67 | 12.90 | 28 |
| Best | 3FLI | 2.78 | 2.48 | 1.56 | 1.83 | 4.58 | 15 | |
| Exp | 2.00 | 2.68 | 2.03 | 4.50 | 14 | |||
| 13 | First | 3OLF | 7.95 | 7.71 | 1.28 | 6.66 | 6.20 | 18 |
| Exp | 0.50 | 0.48 | 1.34 | 7.10 | 9 | |||
| 14 | First | 3OLF | 0.87 | 0.68 | 1.32 | 0.63 | 6.90 | 25 |
| Exp | 0.72 | 0.63 | 0.88 | 7.60 | 13 | |||
| 15 |
| 3OMM | 7.48 | 7.04 | 0.71 | 4.49 | 16.80 | 49 |
| Exp | 1.49 | 1.76 | 1.57 | 4.30 | 10 | |||
| 16 | First | 3DCU | 8.16 | 7.84 | 1.59 | 7.93 | 9.20 | 18 |
| Best | 3FLI | 1.25 | 1.94 | 1.62 | 0.95 | 4.33 | 10 | |
| Exp | 1.53 | 1.76 | 1.58 | 6.30 | 13 | |||
| 17 | First | 3FLI | 1.47 | 1.92 | 1.85 | 1.82 | 3.70 | 10 |
| Exp | 2.21 | 2.25 | 2.03 | 5.40 | 14 | |||
| 18 | First | 3OOF | 8.83 | 8.59 | 1.43 | 7.08 | 8.10 | 20 |
| Exp | 0.92 | 0.88 | 0.93 | 8.80 | 19 | |||
| 19 | First | 3OMM | 1.30 | 0.90 | 0.70 | 1.23 | 7.60 | 26 |
| Exp | 0.96 | 1.29 | 1.01 | 6.10 | 7 | |||
| 20 | First | 3OMM | 6.96 | 6.31 | 1.05 | 4.96 | 7.60 | 24 |
| Best | 3OMK | 0.60 | 0.67 | 0.55 | 1.31 | 5.42 | 11 | |
| Exp | 0.70 | 1.01 | 0.97 | 8.60 | 18 | |||
| 21 | First | 3OMK | 6.27 | 6.25 | 0.56 | 4.73 | 5.90 | 16 |
| Best | 3OMM | 0.95 | 0.79 | 1.15 | 1.28 | 5.85 | 8 | |
| Exp | 0.67 | 1.11 | 1.13 | 7.90 | 18 | |||
| 22 | First | 3OMM | 0.92 | 1.22 | 0.66 | 1.04 | 5.20 | 13 |
| Exp | 1.38 | 1.64 | 1.14 | 5.00 | 13 | |||
| 23 | First | 3HC6 | 7.63 | 7.53 | 0.66 | 5.72 | 8.60 | 39 |
| Exp | 1.03 | 0.89 | 1.21 | 8.10 | 25 | |||
| 24 | First | 3OMK | 6.52 | 6.39 | 0.75 | 4.87 | 6.10 | 13 |
| Best | 3OMM | 1.18 | 0.64 | 1.00 | 1.30 | 5.93 | 9 | |
| Exp | 0.69 | 1.07 | 1.33 | 7.40 | 11 | |||
| 25 | First | 3OMM | 1.65 | 1.73 | 0.68 |
|
|
|
| Best | 3OMM | 0.98 | 0.46 | 1.35 |
|
|
| |
| Exp | 0.47 | 0.60 |
|
|
| |||
| 26 | First | 3OMK | 7.89 | 7.66 | 1.48 | 6.23 | 4.90 | 8 |
| Best | 3OMM | 1.23 | 1.24 | 1.10 | 1.39 | 5.67 | 5 | |
| Exp | 0.81 | 0.89 | 0.99 | 4.90 | 6 | |||
| 27 | First | 3OMM | 1.25 | 1.33 | 0.81 | 0.93 | 6.00 | 15 |
| Exp | 0.74 | 1.20 | 0.50 | 5.20 | 8 | |||
| 28 | First | 3OMM | 0.77 | 0.57 | 0.92 | 0.83 | 6.00 | 17 |
| Exp | 0.62 | 1.05 | 1.02 | 7.30 | 13 | |||
| 29 | First | 3OMM | 0.79 | 0.92 | 0.71 | 0.96 | 7.00 | 15 |
| Exp | 0.60 | 1.01 | 0.91 | 4.30 | 7 | |||
| 30 | First | 3OMK | 6.43 | 6.45 | 0.78 | 4.65 | 4.30 | 12 |
| Best | 3OLF | 1.82 | 1.62 | 1.02 | 1.92 | 5.70 | 6 | |
| Exp | 0.78 | 1.03 | 0.78 | 5.70 | 9 | |||
| 31 | First | 3OMM | 1.60 | 1.71 | 0.60 | 0.87 | 2.30 | 3 |
| Exp | 0.59 | 0.99 | 1.33 | 5.10 | 12 | |||
| 32 | First | 3OMM | 4.04 | 4.29 | 1.32 | 4.04 | 3.30 | 9 |
| Best | 3OMM | 2.08 | 2.27 | 1.25 | 0.93 | 4.33 | 11 | |
| Exp | 0.80 | 1.16 | 1.12 | 5.10 | 16 | |||
| 34 |
| 3OLF | 5.64 | 5.52 | 1.47 | 5.48 | 12.60 | 15 |
| Exp | 1.59 | 1.56 | 1.39 | 7.50 | 12 | |||
| 35 | First | 3OOF | 0.40 | 0.77 | 1.48 | 1.14 | 1.20 | 1 |
| Exp | 0.44 | 0.90 | 1.19 | 1.40 | 1 | |||
| 36 | First | 3OMM | 8.12 | 7.82 | 1.24 | 6.80 | 6.40 | 13 |
| Best | 3OMM | 1.37 | 0.90 | 1.16 | 1.04 | 5.81 | 3 | |
| Exp | 0.92 | 0.93 | 1.06 | 6.30 | 5 |
The simulation was started from another docking pose than that given in Table 1, but with similar score
These simulations crashed, probably due to the RMD bias pushing some dihedral angles into ranges where the force field is numerically unstable when used with GROMACS 4.6.2
Fig. 2Scatter plot showing the resulting RMSD towards experiment for the main cluster in the MD simulation (red) and the best cluster in the RMD simulation (blue), for a given RMSD of the initial pose. The line represents no change in RMSD. The right plot is merely a magnification showing the range 0–2.8 Å, corresponding to “reasonably good” initial poses. The right plot also includes the simulations started from experimental poses (which all have an initial RMSD of zero but are slightly displaced along the x axis to avoid cluttering)
Fig. 3Distribution of RMSD from the initial structure over all MD simulations started from docking poses (dock) or experimental structures (exp), as well as all RMD simulations started from the experimental structures (RMD)
Fig. 4Example of the behavior of RMD for the arbitrary ligands 1 and 2, and for the various choices of CVs for ligand 5. The scatter plots show the RMSD towards the initial pose versus the RMSD towards experiment for each of the RMD clusters (blue), as well as for the MD cluster (red) and the initial docking pose (green), for reference. For ligand 5, results for three RMD variants are shown: the standard settings with only ligand dihedrals (blue), the inclusion of sidechain CVs (magenta), and the inclusion of rotation-promoting CVs (cyan). In addition, the results for an independent simulation with the standard settings are shown (black); the latter is used for the analysis in Table 4. Note that the simulation with rotational CVs was only run for 8 ns due to technical problems; significantly more clusters would probably have been visited if it had been run for 20 ns like all the others
Fig. 5Protein–ligand complex for ligand 11 from experiment (cyan), MD simulation (green) and RMD simulation (orange) superimposed over each other (a). The magnification shows only the ligand of these three complexes and highlights the difference in binding pose among them (b)
Fig. 62D ligand interaction map of complexes for ligand 11 from experiment (a), MD simulation (b) and RMD simulation (c). Hydrogen bonds are depicted as dashed lines between the atoms involved, whereas hydrophobic contacts are represented by an arc with spokes radiating towards the ligand atom. Protein–ligand interaction analysis was performed using UCSF Chimera and LigPlot [52] software. LigPlot automatically generates schematic diagrams for protein–ligand interaction for a given geometry